APO Research
Talk to an analyst

APO RESEARCH · REPORT

Bio-protein Drug

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Bio-protein Drug Market Outlook and Growth Opportunities 2026

26 December 2025207 pages

Choose your research edition.

Industry ResearchBio-protein Drug Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Bio-protein Drug Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Bio-protein Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bio-protein Drug Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Bio-protein Drug Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global Bio-protein Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Bio-protein Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Bio-protein Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Bio-protein Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Bio-protein Drug market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Bio-protein Drug market include Abbott Laboratories, Sanofi, Johnson & Johnson, Novartis AG, Merck, Roche, GlaxoSmithKline, Bayer AG and Amgen Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Bio-protein Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Bio-protein Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Bio-protein Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Bio-protein Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Bio-protein Drug Segment by Company

Abbott Laboratories

Sanofi

Johnson & Johnson

Novartis AG

Merck

Roche

GlaxoSmithKline

Bayer AG

Amgen Inc.

Reliance Life Science Pvt. Ltd.

ProBioGen AG

Panacea Biotec

Fresenius kabi

Eli Lilly and Company

Dr. Reddy’s Laboratories

Biocon Ltd.

Bio-protein Drug Segment by Type

Therapeutic Proteins

Vaccines

Monoclonal Antibodies

Bio-protein Drug Segment by Application

CROs

Academics

Pharma and Biotech Companies

Bio-protein Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Bio-protein Drug status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Bio-protein Drug market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Bio-protein Drug significant trends, drivers, influence factors in global and regions.

6. To analyze Bio-protein Drug competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bio-protein Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bio-protein Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bio-protein Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Bio-protein Drug market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Bio-protein Drug industry.

Chapter 3: Detailed analysis of Bio-protein Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Bio-protein Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Bio-protein Drug in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Bio-protein Drug Industry Trends Table 2. Bio-protein Drug Industry Drivers Table 3. Bio-protein Drug Industry Opportunities and Challenges Table 4. Bio-protein Drug Industry Restraints Table 5. Global Bio-protein Drug Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Bio-protein Drug Revenue Share by Company (2021-2026) Table 7. Global Bio-protein Drug Sales Volume by Company (W Tons) & (2021-2026) Table 8. Global Bio-protein Drug Sales Volume Share by Company (2021-2026) Table 9. Global Bio-protein Drug Average Price (US$/Ton) of Company (2021-2026) Table 10. Global Bio-protein Drug Company Ranking, (2024-2026) & (USD Million) Table 11. Global Bio-protein Drug Key Company Manufacturing Base & Headquarters Table 12. Global Bio-protein Drug Company, Product Type & Application Table 13. Global Bio-protein Drug Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Bio-protein Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Therapeutic Proteins Table 18. Significant Companies of Vaccines Table 19. Significant Companies of Monoclonal Antibodies Table 20. Global Bio-protein Drug Sales Volume by Type 2021 VS 2025 VS 2032 (W Tons) Table 21. Global Bio-protein Drug Sales Volume by Type (2021-2026) & (W Tons) Table 22. Global Bio-protein Drug Sales Volume by Type (2027-2032) & (W Tons) Table 23. Global Bio-protein Drug Sales Volume Share by Type (2021-2026) Table 24. Global Bio-protein Drug Sales Volume Share by Type (2027-2032) Table 25. Global Bio-protein Drug Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Bio-protein Drug Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Bio-protein Drug Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Bio-protein Drug Sales Value Share by Type (2021-2026) Table 29. Global Bio-protein Drug Sales Value Share by Type (2027-2032) Table 30. Significant Companies of CROs Table 31. Significant Companies of Academics Table 32. Significant Companies of Pharma and Biotech Companies Table 33. Global Bio-protein Drug Sales Volume by Application 2021 VS 2025 VS 2032 (W Tons) Table 34. Global Bio-protein Drug Sales Volume by Application (2021-2026) & (W Tons) Table 35. Global Bio-protein Drug Sales Volume by Application (2027-2032) & (W Tons) Table 36. Global Bio-protein Drug Sales Volume Share by Application (2021-2026) Table 37. Global Bio-protein Drug Sales Volume Share by Application (2027-2032) Table 38. Global Bio-protein Drug Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Bio-protein Drug Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Bio-protein Drug Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Bio-protein Drug Sales Value Share by Application (2021-2026) Table 42. Global Bio-protein Drug Sales Value Share by Application (2027-2032) Table 43. Global Bio-protein Drug Sales by Region: 2021 VS 2025 VS 2032 (W Tons) Table 44. Global Bio-protein Drug Sales by Region (2021-2026) & (W Tons) Table 45. Global Bio-protein Drug Sales Market Share by Region (2021-2026) Table 46. Global Bio-protein Drug Sales by Region (2027-2032) & (W Tons) Table 47. Global Bio-protein Drug Sales Market Share by Region (2027-2032) Table 48. Global Bio-protein Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Bio-protein Drug Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Bio-protein Drug Sales Value Share by Region (2021-2026) Table 51. Global Bio-protein Drug Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Bio-protein Drug Sales Value Share by Region (2027-2032) Table 53. Global Bio-protein Drug Market Average Price (US$/Ton) by Region (2021-2026) Table 54. Global Bio-protein Drug Market Average Price (US$/Ton) by Region (2027-2032) Table 55. Global Bio-protein Drug Sales by Country: 2021 VS 2025 VS 2032 (W Tons) Table 56. Global Bio-protein Drug Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Bio-protein Drug Sales by Country (2021-2026) & (W Tons) Table 58. Global Bio-protein Drug Sales Market Share by Country (2021-2026) Table 59. Global Bio-protein Drug Sales by Country (2027-2032) & (W Tons) Table 60. Global Bio-protein Drug Sales Market Share by Country (2027-2032) Table 61. Global Bio-protein Drug Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Bio-protein Drug Sales Value Market Share by Country (2021-2026) Table 63. Global Bio-protein Drug Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Bio-protein Drug Sales Value Market Share by Country (2027-2032) Table 65. Abbott Laboratories Company Information Table 66. Abbott Laboratories Business Overview Table 67. Abbott Laboratories Bio-protein Drug Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 68. Abbott Laboratories Bio-protein Drug Product Portfolio Table 69. Abbott Laboratories Recent Development Table 70. Sanofi Company Information Table 71. Sanofi Business Overview Table 72. Sanofi Bio-protein Drug Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 73. Sanofi Bio-protein Drug Product Portfolio Table 74. Sanofi Recent Development Table 75. Johnson & Johnson Company Information Table 76. Johnson & Johnson Business Overview Table 77. Johnson & Johnson Bio-protein Drug Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 78. Johnson & Johnson Bio-protein Drug Product Portfolio Table 79. Johnson & Johnson Recent Development Table 80. Novartis AG Company Information Table 81. Novartis AG Business Overview Table 82. Novartis AG Bio-protein Drug Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 83. Novartis AG Bio-protein Drug Product Portfolio Table 84. Novartis AG Recent Development Table 85. Merck Company Information Table 86. Merck Business Overview Table 87. Merck Bio-protein Drug Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 88. Merck Bio-protein Drug Product Portfolio Table 89. Merck Recent Development Table 90. Roche Company Information Table 91. Roche Business Overview Table 92. Roche Bio-protein Drug Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 93. Roche Bio-protein Drug Product Portfolio Table 94. Roche Recent Development Table 95. GlaxoSmithKline Company Information Table 96. GlaxoSmithKline Business Overview Table 97. GlaxoSmithKline Bio-protein Drug Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 98. GlaxoSmithKline Bio-protein Drug Product Portfolio Table 99. GlaxoSmithKline Recent Development Table 100. Bayer AG Company Information Table 101. Bayer AG Business Overview Table 102. Bayer AG Bio-protein Drug Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 103. Bayer AG Bio-protein Drug Product Portfolio Table 104. Bayer AG Recent Development Table 105. Amgen Inc. Company Information Table 106. Amgen Inc. Business Overview Table 107. Amgen Inc. Bio-protein Drug Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 108. Amgen Inc. Bio-protein Drug Product Portfolio Table 109. Amgen Inc. Recent Development Table 110. Reliance Life Science Pvt. Ltd. Company Information Table 111. Reliance Life Science Pvt. Ltd. Business Overview Table 112. Reliance Life Science Pvt. Ltd. Bio-protein Drug Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 113. Reliance Life Science Pvt. Ltd. Bio-protein Drug Product Portfolio Table 114. Reliance Life Science Pvt. Ltd. Recent Development Table 115. ProBioGen AG Company Information Table 116. ProBioGen AG Business Overview Table 117. ProBioGen AG Bio-protein Drug Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 118. ProBioGen AG Bio-protein Drug Product Portfolio Table 119. ProBioGen AG Recent Development Table 120. Panacea Biotec Company Information Table 121. Panacea Biotec Business Overview Table 122. Panacea Biotec Bio-protein Drug Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 123. Panacea Biotec Bio-protein Drug Product Portfolio Table 124. Panacea Biotec Recent Development Table 125. Fresenius kabi Company Information Table 126. Fresenius kabi Business Overview Table 127. Fresenius kabi Bio-protein Drug Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 128. Fresenius kabi Bio-protein Drug Product Portfolio Table 129. Fresenius kabi Recent Development Table 130. Eli Lilly and Company Company Information Table 131. Eli Lilly and Company Business Overview Table 132. Eli Lilly and Company Bio-protein Drug Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 133. Eli Lilly and Company Bio-protein Drug Product Portfolio Table 134. Eli Lilly and Company Recent Development Table 135. Dr. Reddy’s Laboratories Company Information Table 136. Dr. Reddy’s Laboratories Business Overview Table 137. Dr. Reddy’s Laboratories Bio-protein Drug Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 138. Dr. Reddy’s Laboratories Bio-protein Drug Product Portfolio Table 139. Dr. Reddy’s Laboratories Recent Development Table 140. Biocon Ltd. Company Information Table 141. Biocon Ltd. Business Overview Table 142. Biocon Ltd. Bio-protein Drug Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 143. Biocon Ltd. Bio-protein Drug Product Portfolio Table 144. Biocon Ltd. Recent Development Table 145. Key Raw Materials Table 146. Raw Materials Key Suppliers Table 147. Bio-protein Drug Distributors List Table 148. Bio-protein Drug Customers List Table 149. Research Programs/Design for This Report Table 150. Authors List of This Report Table 151. Secondary Sources Table 152. Primary Sources List of Figures Figure 1. Bio-protein Drug Product Image Figure 2. Global Bio-protein Drug Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bio-protein Drug Sales Value (2021-2032) & (US$ Million) Figure 4. Global Bio-protein Drug Sales (2021-2032) & (W Tons) Figure 5. Global Bio-protein Drug Sales Average Price (US$/Ton) & (2021-2032) Figure 6. Global Bio-protein Drug Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Therapeutic Proteins Image Figure 10. Vaccines Image Figure 11. Monoclonal Antibodies Image Figure 12. Global Bio-protein Drug Sales Volume by Type (2021 VS 2025 VS 2032) & (W Tons) Figure 13. Global Bio-protein Drug Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Bio-protein Drug Sales Volume Share by Type (2021-2032) Figure 15. Global Bio-protein Drug Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Bio-protein Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Bio-protein Drug Sales Value Share by Type (2021-2032) Figure 18. CROs Image Figure 19. Academics Image Figure 20. Pharma and Biotech Companies Image Figure 21. Global Bio-protein Drug Sales Volume by Application (2021 VS 2025 VS 2032) & (W Tons) Figure 22. Global Bio-protein Drug Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Bio-protein Drug Sales Volume Share by Application (2021-2032) Figure 24. Global Bio-protein Drug Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Bio-protein Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Bio-protein Drug Sales Value Share by Application (2021-2032) Figure 27. Global Bio-protein Drug Sales by Region: 2021 VS 2025 VS 2032 (W Tons) Figure 28. Global Bio-protein Drug Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Bio-protein Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Bio-protein Drug Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Bio-protein Drug Sales Value (2021-2032) & (US$ Million) Figure 32. North America Bio-protein Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Bio-protein Drug Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Bio-protein Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Bio-protein Drug Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Bio-protein Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Bio-protein Drug Sales Value (2021-2032) & (US$ Million) Figure 38. South America Bio-protein Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Bio-protein Drug Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Bio-protein Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Bio-protein Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Bio-protein Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Bio-protein Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Bio-protein Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Bio-protein Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Bio-protein Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Bio-protein Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Bio-protein Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Bio-protein Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Bio-protein Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Bio-protein Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Bio-protein Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Bio-protein Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Bio-protein Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Bio-protein Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Bio-protein Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Bio-protein Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Bio-protein Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Bio-protein Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Bio-protein Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Bio-protein Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Bio-protein Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Bio-protein Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Bio-protein Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Bio-protein Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Bio-protein Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Bio-protein Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Bio-protein Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Bio-protein Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Bio-protein Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Bio-protein Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Bio-protein Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Bio-protein Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Bio-protein Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Bio-protein Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Bio-protein Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Bio-protein Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Bio-protein Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Bio-protein Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Bio-protein Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Bio-protein Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Bio-protein Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Bio-protein Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Bio-protein Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Bio-protein Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Bio-protein Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Bio-protein Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Bio-protein Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Bio-protein Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Bio-protein Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Bio-protein Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Bio-protein Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Bio-protein Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Bio-protein Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Bio-protein Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Bio-protein Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Bio-protein Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Bio-protein Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Bio-protein Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Bio-protein Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Bio-protein Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Bio-protein Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Bio-protein Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Bio-protein Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Bio-protein Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Bio-protein Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Bio-protein Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Bio-protein Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Bio-protein Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Bio-protein Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Bio-protein Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Bio-protein Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Bio-protein Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Bio-protein Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Bio-protein Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Bio-protein Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Bio-protein Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Bio-protein Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Bio-protein Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Bio-protein Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Bio-protein Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Bio-protein Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Bio-protein Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Bio-protein Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Bio-protein Drug Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Bio-protein Drug Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Therapeutic Proteins
  • Vaccines
  • Monoclonal Antibodies
Applications
  • CROs
  • Academics
  • Pharma and Biotech Companies
Companies covered
  • Abbott Laboratories
  • Sanofi
  • Johnson & Johnson
  • Novartis AG
  • Merck
  • Roche
  • GlaxoSmithKline
  • Bayer AG
  • Amgen Inc.
  • Reliance Life Science Pvt. Ltd.
  • ProBioGen AG
  • Panacea Biotec
  • Fresenius kabi
  • Eli Lilly and Company
  • Dr. Reddy’s Laboratories
  • Biocon Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Bio-protein Drug Sales Value (2021-2032)
  4. 1.2.2 Global Bio-protein Drug Sales Volume (2021-2032)
  5. 1.2.3 Global Bio-protein Drug Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Bio-protein Drug Market Dynamics
  1. 2.1 Bio-protein Drug Industry Trends
  2. 2.2 Bio-protein Drug Industry Drivers
  3. 2.3 Bio-protein Drug Industry Opportunities and Challenges
  4. 2.4 Bio-protein Drug Industry Restraints
3 Bio-protein Drug Market by Company
  1. 3.1 Global Bio-protein Drug Company Revenue Ranking in 2025
  2. 3.2 Global Bio-protein Drug Revenue by Company (2021-2026)
  3. 3.3 Global Bio-protein Drug Sales Volume by Company (2021-2026)
  4. 3.4 Global Bio-protein Drug Average Price by Company (2021-2026)
  5. 3.5 Global Bio-protein Drug Company Ranking (2024-2026)
  6. 3.6 Global Bio-protein Drug Company Manufacturing Base and Headquarters
  7. 3.7 Global Bio-protein Drug Company Product Type and Application
  8. 3.8 Global Bio-protein Drug Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Bio-protein Drug Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Bio-protein Drug Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Bio-protein Drug Market by Type
  1. 4.1 Bio-protein Drug Type Introduction
  2. 4.1.1 Therapeutic Proteins
  3. 4.1.2 Vaccines
  4. 4.1.3 Monoclonal Antibodies
  5. 4.2 Global Bio-protein Drug Sales Volume by Type
  6. 4.2.1 Global Bio-protein Drug Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Bio-protein Drug Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Bio-protein Drug Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Bio-protein Drug Sales Value by Type
  10. 4.3.1 Global Bio-protein Drug Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Bio-protein Drug Sales Value by Type (2021-2032)
  12. 4.3.3 Global Bio-protein Drug Sales Value Share by Type (2021-2032)
5 Bio-protein Drug Market by Application
  1. 5.1 Bio-protein Drug Application Introduction
  2. 5.1.1 CROs
  3. 5.1.2 Academics
  4. 5.1.3 Pharma and Biotech Companies
  5. 5.2 Global Bio-protein Drug Sales Volume by Application
  6. 5.2.1 Global Bio-protein Drug Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Bio-protein Drug Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Bio-protein Drug Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Bio-protein Drug Sales Value by Application
  10. 5.3.1 Global Bio-protein Drug Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Bio-protein Drug Sales Value by Application (2021-2032)
  12. 5.3.3 Global Bio-protein Drug Sales Value Share by Application (2021-2032)
6 Bio-protein Drug Regional Sales and Value Analysis
  1. 6.1 Global Bio-protein Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Bio-protein Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Bio-protein Drug Sales by Region: 2021-2026
  4. 6.2.2 Global Bio-protein Drug Sales by Region (2027-2032)
  5. 6.3 Global Bio-protein Drug Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Bio-protein Drug Sales Value by Region (2021-2032)
  7. 6.4.1 Global Bio-protein Drug Sales Value by Region: 2021-2026
  8. 6.4.2 Global Bio-protein Drug Sales Value by Region (2027-2032)
  9. 6.5 Global Bio-protein Drug Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Bio-protein Drug Sales Value (2021-2032)
  12. 6.6.2 North America Bio-protein Drug Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Bio-protein Drug Sales Value (2021-2032)
  15. 6.7.2 Europe Bio-protein Drug Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Bio-protein Drug Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Bio-protein Drug Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Bio-protein Drug Sales Value (2021-2032)
  21. 6.9.2 South America Bio-protein Drug Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Bio-protein Drug Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Bio-protein Drug Sales Value Share by Country, 2025 VS 2032
7 Bio-protein Drug Country-level Sales and Value Analysis
  1. 7.1 Global Bio-protein Drug Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Bio-protein Drug Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Bio-protein Drug Sales by Country (2021-2032)
  4. 7.3.1 Global Bio-protein Drug Sales by Country (2021-2026)
  5. 7.3.2 Global Bio-protein Drug Sales by Country (2027-2032)
  6. 7.4 Global Bio-protein Drug Sales Value by Country (2021-2032)
  7. 7.4.1 Global Bio-protein Drug Sales Value by Country (2021-2026)
  8. 7.4.2 Global Bio-protein Drug Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Bio-protein Drug Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Bio-protein Drug Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Bio-protein Drug Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Bio-protein Drug Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Bio-protein Drug Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Bio-protein Drug Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Bio-protein Drug Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Bio-protein Drug Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Bio-protein Drug Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Bio-protein Drug Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Bio-protein Drug Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Bio-protein Drug Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Bio-protein Drug Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Bio-protein Drug Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Bio-protein Drug Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Bio-protein Drug Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Bio-protein Drug Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Bio-protein Drug Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Bio-protein Drug Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Bio-protein Drug Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Bio-protein Drug Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Bio-protein Drug Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Bio-protein Drug Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Bio-protein Drug Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Bio-protein Drug Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Bio-protein Drug Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Bio-protein Drug Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Bio-protein Drug Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Bio-protein Drug Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Bio-protein Drug Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Bio-protein Drug Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Bio-protein Drug Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Bio-protein Drug Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Bio-protein Drug Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Bio-protein Drug Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Bio-protein Drug Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Bio-protein Drug Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Bio-protein Drug Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Bio-protein Drug Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Bio-protein Drug Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Bio-protein Drug Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Bio-protein Drug Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Bio-protein Drug Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Bio-protein Drug Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Bio-protein Drug Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Bio-protein Drug Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Bio-protein Drug Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Bio-protein Drug Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Bio-protein Drug Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Bio-protein Drug Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Bio-protein Drug Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Bio-protein Drug Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Bio-protein Drug Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Bio-protein Drug Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Bio-protein Drug Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Bio-protein Drug Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Bio-protein Drug Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Bio-protein Drug Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Bio-protein Drug Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Bio-protein Drug Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Bio-protein Drug Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Bio-protein Drug Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Bio-protein Drug Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Bio-protein Drug Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Bio-protein Drug Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Bio-protein Drug Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Bio-protein Drug Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Bio-protein Drug Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Bio-protein Drug Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Bio-protein Drug Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Bio-protein Drug Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Bio-protein Drug Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Bio-protein Drug Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Bio-protein Drug Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Bio-protein Drug Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Bio-protein Drug Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Bio-protein Drug Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Bio-protein Drug Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Bio-protein Drug Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Bio-protein Drug Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Bio-protein Drug Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Bio-protein Drug Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Bio-protein Drug Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Bio-protein Drug Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott Laboratories
  2. 8.1.1 Abbott Laboratories Company Information
  3. 8.1.2 Abbott Laboratories Business Overview
  4. 8.1.3 Abbott Laboratories Bio-protein Drug Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Laboratories Bio-protein Drug Product Portfolio
  6. 8.1.5 Abbott Laboratories Recent Developments
  7. 8.2 Sanofi
  8. 8.2.1 Sanofi Company Information
  9. 8.2.2 Sanofi Business Overview
  10. 8.2.3 Sanofi Bio-protein Drug Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi Bio-protein Drug Product Portfolio
  12. 8.2.5 Sanofi Recent Developments
  13. 8.3 Johnson & Johnson
  14. 8.3.1 Johnson & Johnson Company Information
  15. 8.3.2 Johnson & Johnson Business Overview
  16. 8.3.3 Johnson & Johnson Bio-protein Drug Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Johnson & Johnson Bio-protein Drug Product Portfolio
  18. 8.3.5 Johnson & Johnson Recent Developments
  19. 8.4 Novartis AG
  20. 8.4.1 Novartis AG Company Information
  21. 8.4.2 Novartis AG Business Overview
  22. 8.4.3 Novartis AG Bio-protein Drug Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Novartis AG Bio-protein Drug Product Portfolio
  24. 8.4.5 Novartis AG Recent Developments
  25. 8.5 Merck
  26. 8.5.1 Merck Company Information
  27. 8.5.2 Merck Business Overview
  28. 8.5.3 Merck Bio-protein Drug Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Merck Bio-protein Drug Product Portfolio
  30. 8.5.5 Merck Recent Developments
  31. 8.6 Roche
  32. 8.6.1 Roche Company Information
  33. 8.6.2 Roche Business Overview
  34. 8.6.3 Roche Bio-protein Drug Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Roche Bio-protein Drug Product Portfolio
  36. 8.6.5 Roche Recent Developments
  37. 8.7 GlaxoSmithKline
  38. 8.7.1 GlaxoSmithKline Company Information
  39. 8.7.2 GlaxoSmithKline Business Overview
  40. 8.7.3 GlaxoSmithKline Bio-protein Drug Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 GlaxoSmithKline Bio-protein Drug Product Portfolio
  42. 8.7.5 GlaxoSmithKline Recent Developments
  43. 8.8 Bayer AG
  44. 8.8.1 Bayer AG Company Information
  45. 8.8.2 Bayer AG Business Overview
  46. 8.8.3 Bayer AG Bio-protein Drug Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Bayer AG Bio-protein Drug Product Portfolio
  48. 8.8.5 Bayer AG Recent Developments
  49. 8.9 Amgen Inc.
  50. 8.9.1 Amgen Inc. Company Information
  51. 8.9.2 Amgen Inc. Business Overview
  52. 8.9.3 Amgen Inc. Bio-protein Drug Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Amgen Inc. Bio-protein Drug Product Portfolio
  54. 8.9.5 Amgen Inc. Recent Developments
  55. 8.10 Reliance Life Science Pvt. Ltd.
  56. 8.10.1 Reliance Life Science Pvt. Ltd. Company Information
  57. 8.10.2 Reliance Life Science Pvt. Ltd. Business Overview
  58. 8.10.3 Reliance Life Science Pvt. Ltd. Bio-protein Drug Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Reliance Life Science Pvt. Ltd. Bio-protein Drug Product Portfolio
  60. 8.10.5 Reliance Life Science Pvt. Ltd. Recent Developments
  61. 8.11 ProBioGen AG
  62. 8.11.1 ProBioGen AG Company Information
  63. 8.11.2 ProBioGen AG Business Overview
  64. 8.11.3 ProBioGen AG Bio-protein Drug Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 ProBioGen AG Bio-protein Drug Product Portfolio
  66. 8.11.5 ProBioGen AG Recent Developments
  67. 8.12 Panacea Biotec
  68. 8.12.1 Panacea Biotec Company Information
  69. 8.12.2 Panacea Biotec Business Overview
  70. 8.12.3 Panacea Biotec Bio-protein Drug Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Panacea Biotec Bio-protein Drug Product Portfolio
  72. 8.12.5 Panacea Biotec Recent Developments
  73. 8.13 Fresenius kabi
  74. 8.13.1 Fresenius kabi Company Information
  75. 8.13.2 Fresenius kabi Business Overview
  76. 8.13.3 Fresenius kabi Bio-protein Drug Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Fresenius kabi Bio-protein Drug Product Portfolio
  78. 8.13.5 Fresenius kabi Recent Developments
  79. 8.14 Eli Lilly and Company
  80. 8.14.1 Eli Lilly and Company Company Information
  81. 8.14.2 Eli Lilly and Company Business Overview
  82. 8.14.3 Eli Lilly and Company Bio-protein Drug Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Eli Lilly and Company Bio-protein Drug Product Portfolio
  84. 8.14.5 Eli Lilly and Company Recent Developments
  85. 8.15 Dr. Reddy’s Laboratories
  86. 8.15.1 Dr. Reddy’s Laboratories Company Information
  87. 8.15.2 Dr. Reddy’s Laboratories Business Overview
  88. 8.15.3 Dr. Reddy’s Laboratories Bio-protein Drug Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Dr. Reddy’s Laboratories Bio-protein Drug Product Portfolio
  90. 8.15.5 Dr. Reddy’s Laboratories Recent Developments
  91. 8.16 Biocon Ltd.
  92. 8.16.1 Biocon Ltd. Company Information
  93. 8.16.2 Biocon Ltd. Business Overview
  94. 8.16.3 Biocon Ltd. Bio-protein Drug Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Biocon Ltd. Bio-protein Drug Product Portfolio
  96. 8.16.5 Biocon Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Bio-protein Drug Value Chain Analysis
  2. 9.1.1 Bio-protein Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Bio-protein Drug Sales Mode & Process
  6. 9.2 Bio-protein Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Bio-protein Drug Distributors
  9. 9.2.3 Bio-protein Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst